JULIA
ORIGÜEN SABATER
Profesora asociada de Ciencias de la Salud
MARIO
FERNÁNDEZ RUIZ
Profesor asociado de Ciencias de la Salud
Publications by the researcher in collaboration with MARIO FERNÁNDEZ RUIZ (27)
2024
-
Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324
2023
2022
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
2021
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
International Journal of Infectious Diseases, Vol. 105, pp. 487-494
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
-
Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study
Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842
2020
-
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort
American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462
2019
-
Toxin B PCR amplification cycle threshold adds little to clinical variables for predicting outcomes in clostridium difficile infection: A retrospective cohort study
Journal of Clinical Microbiology, Vol. 57, Núm. 2
2018
-
Características demográficas y de parentesco de los donantes vivos de riñón.
XXII Encuentro Internacional de Investigación en Cuidados
-
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test
Clinical Microbiology and Infection, Vol. 24, Núm. 4, pp. 414-421
-
Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study
Transplant International, Vol. 31, Núm. 2, pp. 187-197
-
Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus
Infectious Diseases, Vol. 50, Núm. 11-12, pp. 837-846
-
Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?
Atherosclerosis, Vol. 269, pp. 204-210
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12
-
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19
2017
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
The Lancet Infectious Diseases, Vol. 17, Núm. 7, pp. 726-734
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
-
Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation
Transplant Infectious Disease, Vol. 19, Núm. 2
2016
-
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Mayo Clinic Proceedings, Vol. 91, Núm. 10, pp. 1362-1371